2023. Effects of the CB1 receptor antagonists AM6545 and AM4113 on metabolic syndrome-induced prostatic hyperplasia in rats. Biomolecules and Biomedicine. 23, 6 (Nov. 2023), 1069–1078. DOI:https://doi.org/10.17305/bb.2023.9173.